table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comers
COVID 19 all comers
anti-interleukin-6
tocilizumab BACC Bay Tocilizumab Trial

1 studies excluded by filtering options 0

5032 TOCOVID, 0 110risk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons